Bourens Myriam, Barrientos Antoni
From the Departments of Neurology and.
From the Departments of Neurology and
J Biol Chem. 2017 May 12;292(19):7774-7783. doi: 10.1074/jbc.M117.778514. Epub 2017 Mar 22.
Defects in mitochondrial cytochrome oxidase or respiratory chain complex IV (CIV) assembly are a frequent cause of human mitochondrial disorders. Specifically, mutations in four conserved assembly factors impinging the biogenesis of the mitochondrion-encoded catalytic core subunit 2 (COX2) result in myopathies. These factors afford stability of newly synthesized COX2 (the dystonia-ataxia syndrome protein COX20), a protein with two transmembrane domains, and maturation of its copper center, Cu (cardiomyopathy proteins SCO1, SCO2, and COA6). COX18 is an additional COX2 assembly factor that belongs to the Oxa1 family of membrane protein insertases. Here, we used a gene-editing approach to generate a human knock-out HEK293T cell line that displays isolated complete CIV deficiency. We demonstrate that COX20 stabilizes COX2 during insertion of its N-proximal transmembrane domain, and subsequently, COX18 transiently interacts with COX2 to promote translocation across the inner membrane of the COX2 C-tail that contains the apo-Cu site. The release of COX18 from this complex coincides with the binding of the SCO1-SCO2-COA6 copper metallation module to COX2-COX20 to finalize COX2 biogenesis. Therefore, COX18 is a new candidate when screening for mitochondrial disorders associated with isolated CIV deficiency.
线粒体细胞色素氧化酶或呼吸链复合物IV(CIV)组装缺陷是人类线粒体疾病的常见原因。具体而言,影响线粒体编码的催化核心亚基2(COX2)生物合成的四种保守组装因子发生突变会导致肌病。这些因子可维持新合成的COX2(肌张力障碍共济失调综合征蛋白COX20)的稳定性,COX20是一种具有两个跨膜结构域的蛋白质,并使其铜中心Cu成熟(心肌病蛋白SCO1、SCO2和COA6)。COX18是另一种COX2组装因子,属于膜蛋白插入酶的Oxa1家族。在这里,我们使用基因编辑方法生成了一种人类敲除HEK293T细胞系,该细胞系表现出孤立的完全CIV缺陷。我们证明,COX20在其N端跨膜结构域插入过程中稳定COX2,随后,COX18与COX2短暂相互作用,促进含有脱辅基铜位点的COX2 C末端跨内膜转运。COX18从该复合物中的释放与SCO1-SCO2-COA6铜金属化模块与COX2-COX20的结合同时发生,以完成COX2的生物合成。因此,在筛查与孤立的CIV缺陷相关的线粒体疾病时,COX18是一个新的候选因素。